doxazosin has been researched along with arginine vasopressin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Cortés-Denia, P; de la Chica-Rodríguez, S; Martínez-Martos, JM; Ramírez-Expósito, MJ | 1 |
1 review(s) available for doxazosin and arginine vasopressin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for doxazosin and arginine vasopressin
| Article | Year |
|---|---|
Effects of alpha1-adrenergic receptor blockade by doxazosin on renin-angiotensin system-regulating aminopeptidase and vasopressin-degrading activities in male and female rat thalamus.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aminopeptidases; Analysis of Variance; Animals; Arginine Vasopressin; Cardiovascular Physiological Phenomena; CD13 Antigens; Cystinyl Aminopeptidase; Doxazosin; Female; Glutamyl Aminopeptidase; Male; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Renin-Angiotensin System; Sex Factors; Statistics, Nonparametric; Thalamus | 2007 |